FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024011063> ?p ?o ?g. }

• W2024011063 endingPage "29" @default.
• W2024011063 startingPage "19" @default.
• W2024011063 abstract "alpha1 Antitrypsin (alpha1AT) is the archetypal member of the serpin superfamily. Current knowledge of its inhibitory mechanism does not provide for any heparin-induced enhancement of serine proteinase inhibition. Since previous results have shown that an apparently altered alpha1AT form may be purified from the plasma of insulin-dependent diabetics by means of heparin-affinity chromatography, in the present work the possibility was tested that heparin at various concentrations modifies the structural conformation and function of human alpha1AT in the absence and presence of glucose, used at concentrations of 15 mM to mimick mild hyperglycemic conditions. Heparin was observed to bind strongly to alpha1AT, causing maximal enhancement of tryptophan fluorescence emission at 50 microg/ml, mostly in the presence of glucose. Circular dichroism spectra revealed that heparin with glucose caused the most relaxed, ordered structure of the inhibitor with increased heat stability. Modification in conformation was accompanied by loss of inhibitory activity, as demonstrated by the inability of alpha1AT to block bovine trypsin in the specific assay and by alterations of its immunological properties. However, despite inactivation, in the presence of heparin-both with and without glucose-alpha1AT was still able to bind trypsin, as revealed by inhibitor-to-proteinase complexes visible in both SDS- and nondenaturing electrophoreses. These complexes showed the same feature regardless of trypsin concentration and differed from those formed at a molar excess of the inhibitor in the absence of heparin, since they underwent rapid, intense fragmentation accompanied by complete loss of the secondary structure of the inhibitor. Even in the absence of trypsin, cleavage of alpha1AT was also observed to occur at both Val321- and Glu344- in the primary sequence of the inhibitor in the presence of 50 microg/ml heparin, with and without glucose. These results suggest that heparin binding to alpha1AT causes profound structural changes in the molecule, involving both the expulsion of the reactive site out of the molecule plane and a relaxed, heat-stable form of the inhibitor, rendered a substrate for the proteinase. Although glucose apparently does not affect alpha1AT functioning, it does enhance the effects of heparin on the alpha1AT structure. The possibility is discussed that, while heparin and glucose binding occurs at different sites on alpha1AT, glucose favors heparin binding by inducing a partially relaxed form in the inhibitor. Differences in structure and charge between the two substances account for both different individual effects on alpha1AT and the predominance of the effects of heparin." @default.
• W2024011063 created "2016-06-24" @default.
• W2024011063 creator A5034288379 @default.
• W2024011063 creator A5077258710 @default.
• W2024011063 date "1997-11-01" @default.
• W2024011063 modified "2023-09-28" @default.
• W2024011063 title "Differential Effects of Heparin and Glucose on Structural Conformation of Human α1Antitrypsin: Evidence for a Heparin-Induced Cleaved Form of the Inhibitor" @default.
• W2024011063 cites W1486977846 @default.
• W2024011063 cites W1493993231 @default.
• W2024011063 cites W1494517489 @default.
• W2024011063 cites W1503784274 @default.
• W2024011063 cites W1524088536 @default.
• W2024011063 cites W1545977948 @default.
• W2024011063 cites W1555987236 @default.
• W2024011063 cites W1562752364 @default.
• W2024011063 cites W1597493507 @default.
• W2024011063 cites W1646314937 @default.
• W2024011063 cites W1932052686 @default.
• W2024011063 cites W1966307718 @default.
• W2024011063 cites W1970372836 @default.
• W2024011063 cites W1977244362 @default.
• W2024011063 cites W1986028457 @default.
• W2024011063 cites W1996362995 @default.
• W2024011063 cites W2001853501 @default.
• W2024011063 cites W2006876120 @default.
• W2024011063 cites W2013749636 @default.
• W2024011063 cites W2016977751 @default.
• W2024011063 cites W2024582763 @default.
• W2024011063 cites W2045203290 @default.
• W2024011063 cites W2046574852 @default.
• W2024011063 cites W2060372493 @default.
• W2024011063 cites W2066729648 @default.
• W2024011063 cites W2075529325 @default.
• W2024011063 cites W2084843263 @default.
• W2024011063 cites W2092077367 @default.
• W2024011063 cites W2100837269 @default.
• W2024011063 cites W2107873069 @default.
• W2024011063 cites W2239384431 @default.
• W2024011063 cites W330357786 @default.
• W2024011063 cites W4237237051 @default.
• W2024011063 cites W4293247451 @default.
• W2024011063 doi "https://doi.org/10.1006/abbi.1997.0317" @default.
• W2024011063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9344460" @default.
• W2024011063 hasPublicationYear "1997" @default.
• W2024011063 type Work @default.
• W2024011063 sameAs 2024011063 @default.
• W2024011063 citedByCount "9" @default.
• W2024011063 crossrefType "journal-article" @default.
• W2024011063 hasAuthorship W2024011063A5034288379 @default.
• W2024011063 hasAuthorship W2024011063A5077258710 @default.
• W2024011063 hasConcept C104317684 @default.
• W2024011063 hasConcept C133571119 @default.
• W2024011063 hasConcept C181199279 @default.
• W2024011063 hasConcept C185592680 @default.
• W2024011063 hasConcept C2776706248 @default.
• W2024011063 hasConcept C2777557582 @default.
• W2024011063 hasConcept C2778965386 @default.
• W2024011063 hasConcept C2780340462 @default.
• W2024011063 hasConcept C515207424 @default.
• W2024011063 hasConcept C55493867 @default.
• W2024011063 hasConceptScore W2024011063C104317684 @default.
• W2024011063 hasConceptScore W2024011063C133571119 @default.
• W2024011063 hasConceptScore W2024011063C181199279 @default.
• W2024011063 hasConceptScore W2024011063C185592680 @default.
• W2024011063 hasConceptScore W2024011063C2776706248 @default.
• W2024011063 hasConceptScore W2024011063C2777557582 @default.
• W2024011063 hasConceptScore W2024011063C2778965386 @default.
• W2024011063 hasConceptScore W2024011063C2780340462 @default.
• W2024011063 hasConceptScore W2024011063C515207424 @default.
• W2024011063 hasConceptScore W2024011063C55493867 @default.
• W2024011063 hasIssue "1" @default.
• W2024011063 hasLocation W20240110631 @default.
• W2024011063 hasLocation W20240110632 @default.
• W2024011063 hasOpenAccess W2024011063 @default.
• W2024011063 hasPrimaryLocation W20240110631 @default.
• W2024011063 hasRelatedWork W2007330433 @default.
• W2024011063 hasRelatedWork W2021006564 @default.
• W2024011063 hasRelatedWork W2024011063 @default.
• W2024011063 hasRelatedWork W2028342403 @default.
• W2024011063 hasRelatedWork W2036790465 @default.
• W2024011063 hasRelatedWork W2078595220 @default.
• W2024011063 hasRelatedWork W2232949067 @default.
• W2024011063 hasRelatedWork W2325762850 @default.
• W2024011063 hasRelatedWork W2403413280 @default.
• W2024011063 hasRelatedWork W3010056926 @default.
• W2024011063 hasVolume "347" @default.
• W2024011063 isParatext "false" @default.
• W2024011063 isRetracted "false" @default.
• W2024011063 magId "2024011063" @default.
• W2024011063 workType "article" @default.